Skip to main content
Search
Close Search
Menu
About
Team
Psychedelics
Clinical Trials
KRN-101
Psychedelic Training
Commercialization
Development Pipeline
Neuro Nature
Neuropath AI
Investors
News
Contact
Industry News
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
December 30, 2016
1 min read
Share
Share
Share
Share
Pin
Close Menu
About
Team
Psychedelics
Clinical Trials
KRN-101
Psychedelic Training
Commercialization
Development Pipeline
Neuro Nature
Neuropath AI
Investors
News
Contact
About Salient
The Castle
Unit 345
2500 Castle Dr
Manhattan, NY
T:
+216 (0)40 3629 4753
E:
hello@themenectar.com